Latest Funds Under Administration News

Paradigm Biopharmaceuticals has entered voluntary administration after its pivotal Phase 3 trial produced an interim efficacy result below the threshold required for continuation. The company’s securities will remain suspended while administrators assess its viability, liabilities and possible restructuring options.

Perpetual returned to statutory profitability in FY26 and lifted underlying profit and dividends, helped by Corporate Trust and cost savings. But the annual report also exposes the pressure points behind the recovery: $25.1 billion in Asset Management outflows, a $63.5 million TSW impairment and an uncertain Wealth Management sale.

Jameson Resources has opened the retail leg of a A$5 million accelerated entitlement offer, giving eligible shareholders the chance to buy new shares at a 22.2% discount to the latest stated closing price. The company says institutional demand has already delivered about A$3.7 million, with a further A$1.59 million placement, but the retail component remains non-underwritten.

Kina Securities lifted its half-year net profit by 4% to PGK 59.7 million, underpinned by a strong capital injection via Papua New Guinea’s inaugural listed corporate bond and a 13% higher interim dividend in local currency.

Praemium Limited reported a 5.7% revenue increase to $110.5 million and a 21.1% jump in funds under administration to $77.9 billion for FY26, driven by strong high-net-worth segment growth and the integration of OneVue. The acquisition of Technotia Laboratories and a major technology restructure signal a sharpened focus on innovation and cost efficiency.

Netwealth Group posted record FY26 revenue of $391 million, up 21%, with adjusted net profit rising 16.2% to $135.4 million after excluding $105 million in First Guardian compensation. The company declared a fully franked 21-cent final dividend, maintaining a 9.1% increase in total dividends.

Centrepoint Alliance reported a 24% jump in net profit to $6.4 million for FY26, underpinned by a 16% rise in EBITDA and advances in artificial intelligence initiatives. The company declared a steady fully franked dividend of 1.75 cents per share and expanded its salaried advice business through acquisitions.

Perpetual Limited will book a non-cash A$63.5 million impairment on goodwill tied to Thompson, Siegel & Walmsley’s International Equity strategy after a major client announced plans to redeem US$4.6 billion in Q2 FY27.

NZX Limited reported a robust first half of 2026 with operating earnings up 9.4% and net profit rising 18%. The exchange strengthened its funds management and wealth administration arms, relaunched equity derivatives, and declared a higher interim dividend. A new CEO is set to take the helm in September.

HUB24 Limited (ASX:HUB) delivered a standout FY26 with 23% revenue growth, 30% EBITDA increase, and record platform net inflows of $18.9 billion, while boosting dividends by 39%.

Fiducian Group posted solid underlying earnings growth in FY2026, boosted by a 7% rise in funds under management, advice and administration, while absorbing a one-off $7.95 million ASIC penalty that halved statutory profits.

Perpetual Limited recorded solid growth across its divisions in Q4 FY26, with Corporate Trust and Asset Management buoyed by market gains despite net outflows. The company is advancing the sale of its Wealth Management arm to Bain Capital, targeting completion in late 2026.